IV ONE opens in Riyadh to revolutionize infusion therapy care for patients with chronic conditions

Short Url

IV ONE, the first dedicated medical intravenous therapy center in Saudi Arabia, has opened its doors and is accepting patients this month, marking a significant milestone in the transformation and delivery of infusion therapy for patients with chronic illnesses, autoimmune disorders, and nutrient deficiencies in the Kingdom and GCC region.

Incubated by TVM Capital Healthcare, a global growth capital firm targeting unmet medical needs in emerging markets, IV ONE is the first of its kind in Saudi Arabia and positioned to become the Kingdom’s premier referral hub for outpatient infusion therapy. 

IV ONE places significant emphasis on addressing the unique needs of every patient, thereby enhancing the quality of care and patient experience, reducing the time to service, enhancing drug adherence, and generally the clinical outcomes. The IV ONE team comprises specialized infusion nurses, pharmacists, and physicians, as well as administrative professionals with decades of experience in healthcare management and service delivery. 

With a fully integrated health information system, patients and physicians can expect seamless communication with clinical experts throughout the entire care journey, from referral to post-treatment care. This results in better health outcomes and a higher quality of life, through improved management of patients’ long-term treatment needs in a way that minimizes disruption to their daily lives.

“IV ONE is dedicated to revolutionizing access to specialized infusion therapy and enhancing the lives of individuals with long-term and chronic conditions,” said Michael Davis, chairman of IV ONE. “Our vision aligns with the Kingdom’s Vision 2030 and National Health Transformation Program’s healthcare goals.” 

“Given the tremendous need for high quality and efficient infusion clinics outside of the hospital, we have already begun laying the groundwork for expansion across the Kingdom over the next three years,” said Ghida Harfouche, partner at TVM Capital Healthcare. 

Dr. Yazeed Al-Sufyani, chief commercial officer of IV ONE, added: “This project aims to provide cost-effective, high-quality healthcare solutions while offering unparalleled patient experience. Starting in Riyadh, we look forward to providing the service across the Kingdom.”